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Urinary Tract Isolates of Haemophilus 
parainfluenure are Distinct by Repetitive 
Extragenic Palindromic (REP)-PCR and Cellular 
Fatty Acid (CFA) Analysis 
J.E. Clarridge. VA Mediral Center and Baylor College ofMedin'ne, 
Houston Exas, USA 
Objectives: To assess heterogeneity of Haemophilur spp. using 
REP-PCR and cellular fatty acid analysis. 
Methods: We defined Haemophilus spp. isolated from an adult 
predominantly male population by biochemical profile, site of isola- 
tion, REP-PCR pattern and CFA analysis (MIDI system). 
Results: In contrast to Haemophilus ducreyi, which was homoge- 
neous by all measures, both H .  parainzuenzae and H .  injuenrae were 
heterogeneous. However a group of urinary tract isolates of Hparain- 
juenzae clustered by CFA analysis at a Euclidean distance of 6 and 
showed a single PCR pattern and only a few biochemical profiles. 
These isolates occurred as both pathogens and normal urethral flora. 
H parainjuenzae from other sources gave about ten PCR patterns 
and CFA clusters. H .  parainjuenzae and H .  influenzae isolates from 
urine were not associated with concurrent respiratory mfection. 
Conclusion: REP-PCR and CFA pattern analysis can distinguish 
a cryptic group of urinary tract isolates of Haemophilus parainjuenzoe 
that can be clinically sigdcant. 
IP1106) Polish National External Quality Assesment 
Scheme for Microbiology (POLMICRO) 
T. Zarqba, 'w. Hryniewicz. Sera G Vacn'nes Central Research 
Lboratov  Warsaq Poland 
Objectives: Microbiology Laboratories throughout the world par- 
ticipate in external quality assessment schemes, often as a prerequisite 
for accreditation. The POLMICRO established in December 1993 
provides a quality assessment scheme service in bacteriology and an- 
tibiotic susceptibility testing (AST). 
Methods: Participation was voluntary although it was strongly 
recommended, especially for laboratories chaired by district consul- 
tants. 5-6 samples for bacterial identification and antibiotic suscepti- 
bility testing were dispatched in each distribution. Participants were 
given one month to examine and return the results. All participat- 
ing laboratories were informed about their overall performance and 
where necessary comments were made in an effort to improve the 
standards of testing. 
Results: The number of participants in the POLMICRO var- 
ied from 81 to 100 laboratories. Over the three assessment periods 
the percentage of participants returning reports that were considered 
satisfactory was increased from 27% to 76%. Results of idenafica- 
tion were generally acceptable except for Sheptocouus pneumoniae. 
Most discrepancies in the scheme were in the area of AST. This 
was presumably because there are more technical and interpretative 
procedures. About 50% of participants in 1993 and 1995, and 6% 
in 1996 failed to detect methidlin resistance of S. aureur. The error 
rates seen in the last two years with penicillin-resistant S. pneumoniae 
and wth  enterococci highly resistant to aminoglycosides were found 
to be 13% and 26%. respectively. 
Conclusion: During the three year period an important increase 
in quality of microbiology laboratory performance was observed. 
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I PI107 I A Novel Assay that Detects and Differentiates 
Chlamydia trachomatis and Neisseia 
gononhoeae Using Transcription Mediated 
Amplification 
J. Shaw, J. Carlson, M. Casdlo, J. Cheung, M. Solomon, P. S d ,  
M. Watson. Gen-Probe Incorporated, San Diego, C4, USA 
Objective: Develop an assay that detects and diEerentiates both 
Neisseria gononhoeae and Chlamydia rrachomatis rRNA from male and 
female urine and swab specimens. 
Methods: Target rRNA is captured out of matrix onto magnetic 
particles as a sample processing method (target capture) that effec- 
tively removes inhibitors of nucleic acid amphfication. The target 
rRNA is amphfied by Transcription Mediated Amplification (TMA). 
The amplification products are hybridized with two Merent acri- 
dinium ester-labeled oligonucleotides that are each specific for the 
two target organisms. Kinetic Werenca in the light-off reactions of 
the two acridimum ester labels, following a hybridmtion protection 
assay, allow for the deconvolution of the signal, and the detection of 
the two analytes in one assay. 
Results: Male and female urine samples (n = 101) were tested 
in a blind study. The assay had a sensitivity of 96.4% (27/28), and a 
specificity of 100% for Chlamydia trachomatis against the Gen-Probe 
AMP CT assay. F&y five endocervical swabs were assayed with 
Gen-Probe's PACE 2 assay as the reference. The dual analyte assay 
was 100% sensitive (8/8), and 97.9% specific (46/47) for Chlamy- 
dia trachomatis. In 10% blood in urine, at the single organism target 
rRNA level, the TMA reaction was not inhibited following target 
capture. In the presence of one million Neissm'a mcningitidis cells, 
the target level equivalent of a single Neisseria gonowhoeae cell could 
be detected. A urine transport buffer compatible with this assay has 
been defined. 
Conclusion: This assay is being designed in concert with an 
inseument that totally automates sample processing, amplification, 
and detection. 
I PI108 I Single-Test Detection of Amplified rRNA from 
Chlamydia trachomatis and Neisseria 
gononhoeae on the VIDAS InstNment 
J.L. Burg 
J. Shaw', G. McKinley', L. Catanzariti ', J. McCarty '. 'bioA4kieu.x 
Ktek, Inc., Rockland, Massachusetts, USA, 'bioMetieux Ktek, Inc., St. 
Louis, Missouri, USA, Gen-Probe, Incorporated, San Diego, Cafijbrnia, 
USA 
A single, rapid and sensitive automated test for the simultaneous de- 
tection of Chlamydia trachomatis (Ct) and Nksseria gononhoeae (Ng) 
is being developed on the VIDAS. This test uses spatially separated 
probes bound to the VIDAS dspensing tip (called the SPR) for 
spedcally capturing Ct and Ng rRNA sequences amplified by the 
transcription-mediated amplification (TMA) technology. If both or- 
ganism are present in a sample, the rRNA from each is co-amphfied 
in a single reaction and individually detected in one VIDAS test strip. 
Signal is produced from alkalme phosphame labeled probes which 
are specific for each amplicon and hybridize to their respective tar- 
gets during the single Capture hybridization step. Total assay time, 
including amplification and detection (but excluding sample pro- 
cessing steps), is about three hours. Discrete results are generated for 
the presence or absence of each target sequence. In model assays 
using purified rRNA molecules, the sensitivity of this test uras about 
100 Ct rRNAs (equivalent to less than one elementary body) and 
4000 Ng rRNAs (equivalent to roughly two cells). These sensitiv- 
L. Meeh ', B. Kluttz ' , J. Moe ', 'w. Weisberg ', 
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ities were only minmdy affected when mixed with a large excess 
of rRNA h r n  the other organism. Assay parameters are currently 
being optimized for discriminating Neisseria gonorrhoeae h m  Neisse- 
ria meningiditis and for dealrig with true samples in c h c a l  matrix. 
The availabihty of a smgle automated test for Ct and Ng - based 
on TMA technology - is an important step in the dmgnosis of these 
sexually transmitted &eases. 
93.1 and 100% for males respectively, while for cell culture these 
values were 72.5, 99.2, 92.5 and 98% for females and 57.4, 99.0, 
86.1 and 95.4% for males, respectively. 
Conclusions: We conclude that the TMA-CT is a fast and reli- 
able test to detect C. trachomatis in urine specimens in females and, 
in particular, males. 
Development of an Amplified VIDAS Test for 
the Detection of Chlamydia trachomatis from 
Urogenital Samples 
M. Vera-Garcia I ,  P. Wells * , W Lauzier ' , A. Fbneri I ,  
W O'Brien ', B. Kluttz ', J. Moe I ,  G. McKinley I ,  J. Burns ', 
K. Clark ', M. Longiaru ', L. Catanzariti ' . ' bioMhiewc Mtek, Inc., 
Rockland, Massachusetts, USA, 2Gen-Probe Incorporated., Sun Diep, 
Calijornia, USA 
Objective: To develop a rapid, automated and amplified test for spe- 
cific and sensitive detection of Chlamydia trachomatis h o r n  urogenital 
samples. 
Methods: Chlamydia trachomatis rRNA was ampued h m  Pan- 
els of clinically important serovars and urogenital samples us- 
ing Transcription Mediated Amplification (TMA) followed by en- 
zyme-linked fluorescent detection within the standard bioM6rieux 
VIDAS immunoassay instrument. Addnionally, the amplified prod- 
ucts were also analyzed using Gen-Probe's Hybridization Protection 
Assay (HPA). 
Results: A total of 120 cervical swabs and 78 urine (29 female, 
49 male) were tested. The data showed a 100% correlation between 
VIDAS and HPA detection. All culture and PACE (Gen-Probe) pos- 
itive samples were detected by the VtDAS assay. Analytical sensitivity 
was equivalent to 0.5 4: of rRNA (l/lOth of an elementary body). 
Clinical isolates containing blood and mucosal residue were not in- 
hibitory to both amplification and W A S  detection. The results 
were obtained in less than 2 hours. 
Conclusion: These results provide the basis for the development 
of a amplified, rapid and automated assay for the detection of all 
clinically relevant species of Chhmydia trachomatis. 
Performance of the TMA-CT in males and 
females for the detection of Chlamydia 
trachomatis in first voided urine 
J.W Mouton, R.P. Verkooyen, WJ. van der Meijden, 
J.AJ.W Kluytmans, S. Deelen, J.H. van Rijsoort-Vos, 
WH.E Goessens, H.A. Verbrugh. Department of Clinical Microbiology 
and Dmafology, Erasmus University Mediull Center Rotterdam, The 
Netherlandc 
Objectives: A prospective evaluation to determine the performance 
of a new commerdy  available amplification assay, the TMA-CT 
(Genprobe Inc) for the detection of C. trachomatis (Ct) in urine 
specimens in comparison with culture. 
Methods: From February 1996 to July 1996, urine samples for 
TMA-CT and urethral and cervical (if applicable) swabs for cell 
culture were collected Emm 1000 patients (544 men and 456 women) 
Discordant results were analyzed using an in-house PCR on both 
origud samples as well as on material obtained h m  the culture 
wells. 
Results: In 130 (13%) patients one or more positive test results 
were obtained. Seventy (7%) of the TMA-CT and cell culture re- 
sults were discordant. After resolution of the &cordant results, the 
sensitivity, spedicity, positive and negative predictive values of the 
TMA-CT were 84.3, 98.8,89.6 and 98% for females and 100,99.2, 
I Pllll I Performance of Three Commercially Available 
Amplification Assays for the Detection of 
Chlamydia tmchomatis in First Voided Urine 
R.P. Verkooyen, J.W Mouton, WJ. van der Meijden, S. Deelen, 
J.H. van Rtjsoort-Vos, W.H.F. Goessens, H.A. Verbrugh. 
Department of Clinical Microbiology and Dermutology, Erasmus University 
Medical Center Rotterdam, rite Netherlands 
Objectives: An prospective evaluation was done to determine the 
performance of the LCR (LC,, Abbott Labs), PCR (COBAS AM- 
PLICOR, Roche Diagnostic Systems) and TMA (Genprobe Inc) for 
the detection of C. trachomatis (Ct) in urine. 
Methods: From 1000 patients, first voided urine, urethral speci- 
men and cervical specimen (if applicable) were obtained. Sensitivity 
and specificity were calculated using a new golden standard; A sam- 
ple was considered to be true positive iftwo or more techniques were 
positive. Discrepant results were retested using an in-house PCR. 
Results: The prevalence in males and females was 12.1% and 
12.5%, respectively. The sensitivity and specificity of cell culture 
was 56 and 99% respectively. The sensitivity of LCx, COBAS AM- 
PLICOR and TMA was 84%, 93% and 85%, respectively. A de- 
creased sensitivity was observed when using female urines. The 
specificity exceeded 99% for all amplification techniques. The abil- 
ity to obtain a positive signal was correlated with the leucocyte 
concentration in urine. A sigdicantly decreased sensitivity of a am- 
plification assays was observed in urines with less than 5 leucocytes 
per ul. 
Conclusions: We conclude that urine may serve as an adequate 
alternative patient specimen for the detection of C. trarhomatis when 
using amplification assays. The sensitivity of the amplification as- 
says for the detection of C. trachomatis in urine strongly depends 
on the sex of the patient and the presence of leucocytes in urine. 
The COBAS AMPLICOR seems to be least affected by h s  phe- 
nomenon. 
Detection of Prevalence of Infections with 
Chlamydia trachomatis (CT) in an Obstetrics 
and Gynaecological (O&G) OPD by Molecular 
Analysis of Urine Samples 
M. Craandijk I ,  C. Peters I ,  J. Mutsaers ', P. Oostvogel', J. Dorr ' . 
'Department ofOG.G, Westeinde Hospital, The Hague, NL., 
'Department $Medical Microbiology, Westeinde Hospital, The Hague, 
NL. 
Objectives: Assesment of prevalence of infections with Chlamydia 
trachomatis (CTI) in an O&G OPD by molecular urine analysis. 
Methods: New patients h m  our inner city O&G OPD were 
invited to participate in the study. Cervical (C), urethral (rr, and anal 
swab specimens were taken h m  patients for detection of CT-DNA 
(Gen-Probe, PACE 2"). Urine samples were collected for detection 
of CT-rRNA (Gen-Probe, Amplified"). 
Results During the first 4 months of our study 599 patients 
were enrolled, of whch 120 patients refused participation. Of 479 
remaining patients, 16 were found positive in either the C- and/or 
the U- swab or in the urine assay. In this p u p  the prevalence of 
CT infection (CTI) is 3.3%. Of 16 patients with CTI, the probe 
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was positive in 14 cases: 10 x C and 4 x U. Two patients with 
a positive C turned out to be negative in urine analysis. Of two 
remaining patients with CTI detected by positive urine-test, only 
one had negative probes, for the other none were adable.  
Conclusions: 1. The prevalence of CT determined so far in our 
population IS 3.3%. This figure is low compared to the 6% as was 
found in other inner city hospitals. 2. Molecular urine analysis for 
CT appears to be a reliable and easy method for population studies, 
in comparison with cervical- and urethral-swab techniques. 
Results: Inhibitors were present in 0%, 40%, 55% and 50% resp. 
in group I, 11, 111, IV. The mean % inhibition was resp. 0%, 25%, 
18% and 70%. LCR inhibition was removed by dilution in 3/4, 
4/5, 3/52 urines in resp. group 11, 111, Iv. The mean % of inhibition 
remaining after dilution was 7%, 13% and 66% in resp. group 11,111, 
IV. 
Conclusion: Urine specimens with leucocyturia or hematuria 
show moderate LCR inhibition, usudy removable with dilution. In 
urine specimens with cristaluria strong LCR inhibition was demon- 
strated not always removable with dilution. 
I PI113 I Performance of the Cobas Amplicor and the 
LCx on lnvasive and Non-lnvasive Samples for 
the Diagnosis of Genital Chlamydia1 Infections 
A. Stary, B. Hartmann, E. Schuh, A. Koch. Outpatients’ Centrefor 
In>ctious Wnero-Dermatological Diseases, Wenna, Austria 
Objective: To Compare the performance of the COBAS AM- 
PLICOR CT test and the LCx Chlamydia harhomatis assay using 
invasive and non-invasive samples in women and men and evaluate 
with culture. 
Methods: The study was performed in a total of 467 patients (264 
men and 203 women) examined for a genital chlamyd~al mfection.. 
In males, urethral and urine samples and in females, samples from 
the endocervical canal, vulval region, and urine were tested by both 
DNA ampldjmg methods and compared with culture on urethral 
or endocervical specimens. Discrepant results were analysed by the 
DFA and MOW-PCR and calculations were assessed by a gold 
standard based on the number of infected persons. Inhibition was 
tested by the use of an internal control adable  for the COBAS 
AMPLICOR. 
Results: Evaluating the results for all different tests for all samphg 
sites, 13 women (6.4%) and 34 men (12.9%) were infected with C. 
hahornatis. In women, the detection rate for infected women was 
92.3% for cervical, vulval, and urine samples tested by the LCx and 
92.3% for cervical and urine specimens and 84.6% for vulval smears, 
respectively, tested by Cobas Amplicor. In the 34 infected men, the 
sensitivity for both, COBAS AMPLICOR and LCx was 91.2% for 
urethral specimens, 85.3% for the PCR and 79.4% for the LCR for 
urine. The concordance of both amphfymg methods was high in 
men (95%) and women (99%). The sensitivity for culture was low 
(men 47.1% women 61.5%). 
Conclusion: The results indicate that both amphfjmg methods, 
the COBAS AMPLICOR and LCx showed a high sensitivity for all 
different sampling types of men and women. Non-invasive samples 
such as urine and vulval smears can substitute sampling from the 
cervix and urethra when using ampldication assays. 
m1 Inhibitors of LCR CMarnydia Tracbomaris 
Amplification in Female Urine Specimens 
C. Vael, S. Gaspard. J Paljjn Hospital, Anhuerp, Belgium 
Objectives: To determine the prevalence of inhibitors of LCR 
Chlamydia harhomatis (Cf) amplification in unne specimens in re- 
lation to the microscopical findings of the urine semment and to 
evaluate the efficacy of dilution to remove inhibition. 
Methods: By microscopical examination 40 female urines were 
selected and divided in four groups of 10 specimens each with 
resp. no abnormal findmgs (I), leukocjturia (II), hematuria (111) and 
marked cristaluria (N). Specimens were analysed for C t  with the 
LCX system (Abboa) accordmg to instructions of the manufacturer 
and spiked with Ct calibrator in a final dilution of 1/10. Inhibitory 
specimens were retested diluted 1/10 in urine specimen buffer. In- 
hibition was defined as a reaction rate below the cutoff. 
I Plll5 1 Comparison of Gen-Probe TMA and Roche 
Cobas Amplicor CT for Detection of Cb/amydia 
tracbomatis from Urine Specimens 
R. Pasternack, P. Vuorinen, A. Miettinen. Tampere Uniwsify 
Hospital, Tampere, Finland 
Objectives: To compare TMA with Amplicor PCR in the detec- 
tion of chlamydial infection by using urine specimens. 
Methods: The patients consisted of 339 men and 321 women. 
Urine specimens were prepared for TMA and Amplicor PCR as in- 
structed by the manufacturers within 24 h after specimen collection. 
Both assays were performed according to the manufacturers’ inshuc- 
tions. The internal control protocol was used in conjunction with 
the Cobas Arnplicor PCR assay for all specimens. The ducrepant 
analysis was based on repeated testing of the specimens and, when 
necessary, second sampling and review of the clinical data. 
Results: The results of the two tests were identical for 652 
(98.8%) of the 660 patients. Among them, the test results were uni- 
formly positive for 63 patients. Two true positive specimens were 
negative by PCR. These false results could not be accounted for 
by inhibition. Moreover, there were six specimens that gave positive 
results by PCR in the first run but turned negative on repeated test- 
ing of the specimens. They were considered as false positives by the 
PCR. By the TMA, no false positive results occurred. 
Conclusions: TMA proved to be sensitive and specific in detect- 
ing C. hahornatis in this high risk material. Somewhat unexpectedly, 
both fake positive and false negative results occurred in the auto- 
mated Cobas Amplicor PCR assay. 
I PI116 I Cost-Benefii Analysis of Universal First Void 
Urine Chlamydia Trachomatis Screening 
Program 
J. Paavonen’, M. Puolakkainen’, M. Paukku’, H. Sintonen’. 
’Department of Obsterrirc and Gynecology, Uniuersity ofHelsinlei, 
Finland, ’The Haartman Institute, Uniwrsity $Helsinki, University of 
Kuopio, Finland, ’Department of Health Polity and Management, 
University of Kuopio, Finland 
Background Cost analyses are s t i l l  rare among trials that compare 
pharmacological or procedural health care interventions. 
Objectives: To eduate whether secondary prevention of 
Chlamydia trachomatis infection and associated morbidq in asymp- 
tomatic women is cost-beneficial. 
Methods: We developed a decision tree model, and performed a 
cost-benefit analysis of a Chlamydia trachomatis screening program 
based on first void urine testing of asymptomatic women using a 
PCR test. Selected variables based on assumptions were subjected to 
sensitivity analysis in order to make the model accurate and defensi- 
ble. 
R e s u l ~  The results showed that screening for chlamydial in- 
fections using the PCR test is cost-beneficial in most situations. 
Compared to a no-screening-situation, the direct cost of a universal 
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C. trachomatis screening program with PCR would be less than the 
direct costs of complications caused by chlamydial infections when 
the baseline prevalence of C. trachomatis dection exceeds 3.9%. 
Conclusion: Socioeconomic studies linking secondary preven- 
tion of C. trachoma& infection and infertility/adverse pregnancy 
outcome are needed in order to convince public health authorities 
of the need and benefit of such programs. 
m] Performance of the GEN-PROBE Amplified 
Chlamydia Trachomatis Assay 
D. Ferrero. Sanloquin Co. Regional Public Health Lnborutory, 
Stockton, CaZ$ornia, USA 
Objective: To evaluate the performance of the GEN-PROBE Am- 
plified Chlamydia Trachomatis (AMP CT) assay. 
Method: AMP-CT was compared to cell culture for female en- 
docervical swabs and urine specimens and male urethral swabs and 
urme specimens. Resolution of discrepant specimens was performed 
u&ng a combination of reculture, direct fluorescence antibody 
@FA) staining of specimen sediment, and amplification which tar- 
geted a merent chlamydd rRNA. Endocervical swab specimens 
were collected h m  717 female patients. Urine specimens were col- 
lected h o r n  607 female patients. Urethral swab specimens were col- 
lected h m  209 male patients. Urine specimens were collected h m  
193 male patients. 
Results: 
Specmcn No. AMPCT No. Pos %Por. %Scns. %Spcc. PPV NPV 
~ 
F e d c U r m e  607 29 4.8 93.6 99.5 90.6 99.7 
h4aleUrne 193 23 11.9 88.4 100 100 98.2 
TOTAL 800 52 6.5 91.2 99.6 94.6 99.2 
FemdcSwabr 717 39 5 4  100 100 100 100 
MaleSwabr 209 31 14.8 100 100 100 100 
TOTAL 926 70 7.6 100 100 100 100 
Conclusion: The GEN-PROBE Amplified Chlamydia Tra- 
chomatis assay is a sensitive and specific nudeic acid hybridmtion 
assay for the detection of Chlamydia hahornatis in endocervical and 
male urethral swab specimens and female and male urine specimens. 
Ip11181 Comparison of a Commercially Available PCR 
and LCR Test in the Detection of Urogenital 
Chlamydia trachomatis Infection 
E. Hiltunen-Back ', T. Reunala ', M. Puolakkainen 
F! L a h t e e d 3 ,  J. Paavonen4. 'Haartman Institute, 'Department of 
Dermatology and Venereolygy, 3Family Federation of Finland, 
4Department of Obstetricc and Gynecology, University of Heelsinki, 
Helsinki, Finland 
Objectives: To compare the diagnostic performance of a PCR 
test (Roche COBAS" AMPLICOR'" CT/NG Test) and an LCR 
test (ABBOTT LCx" Chlamydia hahornatis Assay) with endocervi- 
cal/urethcal culture as a reference test. 
Methods: Firs-void urine 0 and endocervical/urethral swab 
(S) specimens were collected h m  1015 patients attending an STD 
clinic and an adolescent clinic in Helsinki, Finland. C. trachomatis 
was cultured &om the endocervix or urethra. PCR was performed 
on urine, and the culture medium. LCR was performed on urine 
and LCx swab transport medium. 
Results: C. truchomatis infection was detected by culture in 6.0%, 
by S-PCR 7.8%, FW-PCR in 7.6%, by S-LCR in 6.6% and by 
FVU-LCR in 6.9%. All five tests gave a positive result in 54 patients. 
Conclusions: Endocervical or urethral culture under-estimates 
the prevalence of C. truchomatis dections in a population. Both 
PCR and LCR performed on swabs and FVU were sensitive and 
specific in detecting C. trachomatis infection. 
I P1119] Prevalence of Antibodies to Chlamydia as 
Measured by EIA and MIF in Relation to Sexual 
Behaviour 
J. Boman ', D. Turpeinen 
of Clin Viroloa, University Hospital of Northm Sweden, Ume& 
Sweden, 'SI IDC,  Stockholm, Sweden, M T C ,  Karolinska Institute, 
Stockholm, Sweden 
Objective: To compare the microimmunofluorescence (MIF) test 
and a novel peptide based Enzyme Immunoassay (EIA) for detection 
of antibodies against C. trachomatis. 
Materials: Among 1002 Swedish women, an age-matched sub- 
sample of 274 women was stratified according to lifetime number 
of sexual partners. Sera from 49 women with only 1 lifetime part- 
ner (mean age 29.1, range 1747)  and from 43 women with >10 
lifetime partners (mean age 29.7, range 1746)  were analyzed. 
Methods: A chlamydia species-specific MIF test (MRL Diagnos- 
tics, California) with LPS-removed elementary bodies (EBs) h m  
C. pneumoniae (Cpn), C. harhomatis (Ctr) and C. p s i t m '  (Cps) was 
used to detect IgG and IgA antibodies against chlamydu. An EIA 
test (Labsystem, Finland) was used for detection of IgG and IgA 
antibodies to Cu. 
Results: Women with r10 partners had sipficantly higher 
prevalence of IgG and IgA antibodies to Ctr as compared to women 
with one lifetime partner @ < 0.0000001); on the contrary, such a 
Merence was not seen of antibodies to Cpn (p = 0.31). Sensitivity 
of the Ctr EN, with MIF as gold standard, was 100% for IgG and 
IgA, while specificity was lower: 87% and 76%. respectively. 
Conclusions: Prevalence of antibodes to Ctr is dependent of the 
number of sexual partners, whereas it is not to Cpn. The use of 
LPS-removed EBs as antigen in the MIF-test enables the differen- 
tiation between Ctr and Cpn antibodies. The Ctr EIA used is very 
sensitive; however, a positive result needs confirmation by MIE 
I. Kallings ', F! Juto I ,  J. Dillner3. ' Dept 
1 PI120 1 Genitourinary Infection by Chlamydia 
Trachomatys in Pregnant Women 
D. Rossi, E. Calzolari, N. Recine, M. Salzano, M. Bavaseelli, 
A. Rossi, M. Midulla. Inst. Pediak Obst. G Gynecolofl, Dep. Human 
Biopath., 'La Sapienza" Uniuerdy, CNR Inst. Exp. Med . ,  Rome, Italy 
Objectives: The purpose of the study was to evaluate the risk of 
Chlamydia trachomatis infection in pregnant women in our geo- 
graphical area. 
Methods: A total of 104 pregant women (age 1942)  attend- 
ing the Clinic of Gynaecology and Obstetrics, University of Rome 
"La Sapienza", were examined for the presence of the pathogen. 
The women selected for the study were between weeks 30 and 39 
of gestation with unbroken membranes. The women treated with 
antibiotic active against C. trachomatis were excluded. Endocervi- 
cal and urethral samples were d e n  with cotton-tipped swabs. The 
specimens were processed using two methods: McCoy cells (CMC) 
treated with cydoheximide and direct test using fluroescein conju- 
gated monoclod antibodies (DFA). At the time of the enquirj- the 
women presented: vaginal discharge (11.5%); urethritis (4.8); cer- 
vicitis (2.8%); vaginitis (9.6%); vulvarprurigo (14.4%); asymptomatic 
(56.7%). 
Results: C. trachmatis was detected by CMC and/or DFA in 
12/104 (11.5%) women; 3 in the cervix only; 6-chlamydia-positive 
in both sites, 3 in the urethra only These women presented 3 
vaginal discharge, 1 urethritis and 8 asymptomatic. 
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Conclusions: We have found that 8/12 (66.6%) or our preg- 
nant women were C. trachomatis-positive and asymptomatic. It is 
therefore important to recognize C. trachomatis infection to prevent 
complications such as premature rupture of membranes, preterm la- 
bor and low birth weight. We can suggest that a correct search of c .  
uachomatis in pregnant women should be done on specimens both 
from the cervix as from the urethra. 
CNT Finahzed Project FATMA. Grant no. 9103613. 
B streptococcus. In none of the cases N. gonorrhoeae was isolated. 
PID developed wihn  7 days in 5.4% of the women. PID developed 
in 22.2% of women positive for C. trachomatis, in 6.3% positive for 
M .  hominis and in 2.4% positive for U urealytinrm. 
Conclusion: According to our results, a sigmficultly lugh risk for 
PID was observed (P = 0.097, o = 0.05) in women with coloniza- 
tion of endocervical canal with C. hachomatis. 
Prevalence of Chlamydia Trachomatis among 
Male Clients of the Prostitutes: Evaluation with 
Demographic and Epidemiologic Findings 
A. Abcfidan', M. Onel', T.Alp', N. I$k ' ,H.hder ' ,  
S. Badur I ,  0. Ang ' . 'Department 4 Mimbiologv, Istanbul Faculty 4 
Medicine 3 4 3 9 0  Capa Lrtanbul, Turkey, 'Department ofUroZosr, Lrtanbul 
Faculty 4Medicine 3 4 3 9 0  c a p a  Lrtanbul, Turkey 
In this study, we investigated the prevalence of C. trachomatis among 
300 men who had sexual contact with prostitutes in Istanbul. All 
study participants were interviewed re@g demographx factors 
and sexual activity. They voluntarily answered all questions. C. tra- 
chomatis was studied in urethral samples by the direct fluorescent 
assay (DFA; Syva, Micro Trak, USA). The mean age of the study par- 
ticipants was 23 f 7.3 Of the men who took place in tlus study, 51 
(17%) were graduated from primary schools, 71 (23.7%) secondary 
schools 104 (34.7%) high schools and 74 (24.7%) universities. 289 
(96.3%) of the men have been living in Istanbul for the last five years. 
It was revealed that of the men 138 (46%) were single and lived with 
their parents, 65 (21.7%) were single and lived alone and 97 (32.3%) 
were married. The mean age of the men for the first sexual contact 
was found to be 18 & 2.3. 272 (90.7%) of men were found to have 
their hrst sexual experience in a brothel. 226 (75.3%) of the dents 
of the prostitutes had sexual contact once a week. Of these men 
28 (9.3%) had the last sexual contact with a registered woman, 242 
(80.7%) with an Eastern European woman. 205 (68.3%) of the men 
used condom during sexual contact with prostitutes. 189 (92.2%) of 
condom users decided themselves to use condom. 296 (98.7%) of 
the men were mostly concerned about AIDS when they had sexual 
contact with prostitutes. 182 (60.7%) of the patients had a previous 
history of STD before this study. The prevalence of C. trachomatis 
among these men was found to be 12%. 
I PI122 I Evaluation of the Risk of Developing Bacterial 
Pelvic Inflammatory Disease (PID) in Pregnant 
Women Prior to Endometrial Curettage 
0 Kisa', M. Baysallar', S. Hakbilen', A. Albay', H. Giin'. 
'Gulhane Military Medical Academy ( G M M A ) ,  Ankara, Turkq 'SSC 
Deliuety Hospital, Ankara, Turkey 
Objectives: To determine the prevalence of the agents colonizing 
the endocervix in pregnant women that would undergo curettage 
operation and to evaluate the effects of preoperative screening and 
treatment programs on postoperative infection morbidity. 
Methods: Enzyme Linked Fluorescent Assay @FA) techmque 
(VIDAS Chlamydia, bioMerieux, France) was used for detecting 
chlamydial anhgens in endocervical specimens. Enrichment me& 
were used for isolation and idenafication of N. gonorrhoeae, M .  homi- 
nu, U. urealytinrm and the other bacterial pathogens. The results were 
evaluated statistidy 
Results: The rate of endocervical colonization with one or more 
Werent bacterial species in 203 pregnant women referred to en- 
domeaial curettage was 53.7%. Of these, 41.4% was due to U. ure- 
alyticum, 15.8% M .  hominis, 8.9% C. hachomatis and 2.0% were group 
I PI1 23 I The Role of Chlamydia in Pelvic Inflammatory 
VM. Semenov, T.I. Dmitrachenko, A.V. Tomchina, D.M. Semenov, 
S.I. Chernyakov. Mtebsk Regional clinical dingnostis laboratory Mtebsk, 
Belarus 
394 women with pelvic dammatory diseases (PID) were investi- 
gated. 75 of them had urethritis, 69 cervicitis, 47 acute endometri- 
tis, 61 chronic endometritis, 59 salpingo-ophoritis, 31 salpingitis, 
24 acute endometritis, salpingo-ophoritis and cervicitis, 18 chronic 
endometritis and salpingo-ophoritis. Detection of Chlamydia an- 
tibodies by immunoenzyme analysis and &a immunofluomcent 
test (h4icroTrak Chlamydia Direct specimen test, Syva, USA) were 
used to diagnose the Chlamydia mf-ection. 
Antibodies to Chlamydia trachomatis were found in 64.4% of ure- 
thritis patients, 67.3% of those with cervicitis, 83.7% with acute 
endometritis, 80.3% with chronic endometritis, 69.2% with salp- 
ingo-ophoritis, 87.5% with salpingitis, 80.9% with acute endometri- 
tis, salpingo-ophoritis and cervicitis, 84.6% with chronic endometri- 
Chlamydia trachomatis were found in 39.4% of urethritis 
patients, 52.3% of those with cervicitis, 26.1% with acute en- 
dometritis, 28.3% with chronic endometritis, 46.2% with salp- 
ingo-ophoritis, 43.9% with salpingitis, 41.6% with acute endometri- 
tis, salpingo-ophoritis and cervicitis, 35.7% with chronic endomeai- 
tis and salpingo-ophoritis. 
Diseases 
tis and salpingo-ophoritis. 
I PI124 I Evolution of the Frequency of Chlamydia1 
Trachornatis Genital Infection in Women during 
5 Years 
M.A. Blanco, A. Saez, 0. Gbmez, E Salazar. H.U Santa CrLtina, 
Madrid, Spain 
Objetives: Study the evolution of the frequency of chlamydial tra- 
chomatis genital infection in patients with suspicion of STD or in 
patients in control of pregnancy. 
Methods: Between 1992 and 1996, 2520 patients, coming from 
the consultations of gynecology and obstetrics of the H.U. Santa 
Cristina, were studied to which carried out them and cer- 
vical exudate for the search of Chamydia and another STD. During 
the years 1992, 1993 and 1994, the technique was ELISA (Pasteur) 
1992 1993 1994 1995 1996 
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and IFD (bioMCrieux) in parallel. During 1995 and 1996, was used 
a rapid DNA probe test which utilizes the technique of nucleic 
acid hybridization for the detection of Chlamydia trachomatis (Gen. 
Probem) and ELFA (VIDAX-bioMCrieux). 
Results: The global frequency of Chlamydia trachomatis was 
fiom 1.6% in 5 years. The distribution according to the years was 
lke expressed in the graph. 
Conclusions: we have found a signhcant descent (p < 0.05) in 
the last years in the isolation of Chlamydia trachomatis, in spite of 
using more sensitive techniques and of the increase of the studied 
population. 
I PI1 25 I Evolution of the Frequency of Ureplasma 
Urealyticum and Mycoplasma Hominis in 
Women during 5 years 
M.A. Blanco, EJ. Sdazar, 0. Gomez, E Izquierdo. H . U  Santa 
Cristina, Madrid, Spain 
Objectives: Know the frequencies of isolations of genitals mycoplas- 
mas in women for 5 years and the clinical symptoms associates. 
Methods: we have studed 2520 patients finm the consultations 
of gynecology and obstetrics, between the years 1992 and 1996, 
to which carried out them vagmal and cervical exudate for the 
mvestigation of genital mycoplasmas and another STD. Transport 
medium was inoculated onto A7 agar plates wich were incubated 
at 37°C in an anaerobes jar for 5 days and examined at second day 
of incubation for evidence of caracteristic colonial morphotypes of 
mycoplasmas. Positive was considered a recount 2 lo4 UFC. 
Results: The global frequency of genitals mycoplasmas in 5 years 
was finm 14.3% for Ureaplasma urealyticum and 0.15% for Myco- 
lasma hominis. 
% 
20 , 
- 
R Mycolasma -n 0 Ureaplasma 
1992 1993 1994 1995 1996 
Conclusions: The kequency of isolation of Ureplasma ure- 
alyhcum has increased sigmficantly (p < 0.05) in the last 5 years. 
There have not been sigmficant Merences (p < 0.05) in the isola- 
tion of Mycoplasma hominis in the 5 years studied. 
I PI126 I Antimicrobial Susceptibility of Ureaplasma 
urealyticurn from Clinical Specimens 
A. Herrero, C. Cuevas, A. Limia, T. Delgado, J. hvarez, 
M. L6pez-BrCa. Dep. ofMicrobioloa, Hospital de la Princeso, Madrid, 
Spain 
Introduction: The emergence of resistance of Ureaplasma urealyticum 
to the usually prescribed antibiotics, presents a challenge in the clin- 
ical practice. 
Objectives: To idenhfy, enumerate semicuantitatively, and study 
the susceptibility of six antibiotic, Doxycycline (DOX), Josamycin 
00s).  Ofloxacin (OFL), Erythromycin (ERY), Tetracycline (TET) 
and Pristinamycin (F'RI). 
Methods: Ninety U urealyticum shains were isolated fiom urine, 
semen and exocervix specimens. The study was followed up with 
the commercial system Mycoplasma IST (BioMCrieux) to deter- 
mine whether the ureaplasma count in the specimen is equal to or 
greater than threshold set at 10 CCU (colour changing unit), and 
the susceptibility pattern. Subcultures were performed soon after the 
media change the colour, using the solid me& A7 agar (Remel 
Laboratories). The susceptibility and resistance for each antibiotic 
were, respectively: DOX (54  mg/l, 28 mg/l), JOS (52  mg/l, 28 
mgll), OFL (51 mgil, 2 4  mgil), ERY ((1 mg/l, z 4  mg/l), TET 
(54  mgA, >8 mg/l), PRI (<2 mgil, >2  mgil). 
The results are shown in the following table: 
DOX JOS OFL ERY TET PRI 
~ ~~ 
% S  93.4 86.8 37.4 5.5 85.7 95.6 
% I  3.3 9.9 53.8 6.6 7.7 0 
%R 3.3 3.3 8.8 87.9 6.6 4.4 
Conclusions: U. urealyticum isolates showed 87.9% of resistance to 
Erythromycin, and 6.6% to Tetracycline. The kequency of acquired 
resistance does not jushfy modifications in the usual treatment of 
genital mycoplasma infections, but leads to monitor their suscepti- 
bility to antibiotics. 
I PI1 271 Susceptibility of Ureaplasma urealyticurn to 
P Senji, L. iele-Startevii, S .  KaleniE. Clinical Hospital Centre Zagreb, 
Zagreb, Croatia 
Objectives: Our goal was to determine the in vim susceptibility 
of Ureaplasma urealyticum (Uu.) isolates to doxycycline, tetracycline, 
erythromycine and ofloxacin. 
Methods: Ureaplasma urealyticum has been isolated and determi- 
nated semiquantitatively on Mycoplasma Lyo agar (bioMerieux, Lyon, 
France). The antimicrobial susceptibility testing was performed with 
commercial test Mycoplasma IST (bioMerieux). 
Results: During three months period we had 1012 samples (163 
samples of male urethra and 849 cervical samples). Ureaplasma ure- 
alyticum was isolated &om urethral samples in 25 men (15.0%) and 
finm cervical samples in 167 women (19.6%). In men Ureaplasma 
urealyticum was isolated in sigdcant number (?lo4) in 18 samples 
(72.0%), and in low number &lo3) in 7 (28.0%) samples respec- 
tively. In women U.U. was isolated in sigdicant number in 49.7%, 
and in low number in 50.3% samples, respectively. The antimicrobial 
susceptibdity was as follows: strains were susceptible on doxycycline 
in 97.7% and resistant in 2.3%; on ofloxacin in 43% susceptible, in 
48.8% moderately susceptible and in 2.3% resistant; on erythromycin 
in 1.2% susceptible, in 50.0% moderately susceptible and in 48.8% 
resistant; on tetracycline in 95.4% susceptible and in 4.5% resis- 
tant. 
Conclusions: The emerging resistance of Ureaphma urealyticum 
to certain antibiotics emphasizes the need for further survedlance 
studies on the clinical isolates of such organisms. 
Antibiotics 
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I PI128 I Sexually Transmitted Diseases in Senegalese 
G.A. Botta', G. Raphenon2, C. Botta', C. Courdet2. 'Lttituto di 
Minobiologia, Facoltir di Medicina e Chirurgia 33100 Udine, Italy, 
ZInstitut Pasteur, Dakar, Senegal 
Objectives: To assess the incidence of sexually mnxnitted 
Women 
